Appropriateness of antimicrobial therapy: A multicentre prevalence survey in the Netherlands, 2008-2009

Eurosurveillance

Volumn 15, Issue 46, 2010, Pages

  Willemsen, I ^a   van der Kooij, T ^b   van Benthem, B ^b   Wille, J ^c   Kluytmans, J ^a,d  

^a AMPHIA HOSPITAL   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c Dutch Institute for Healthcare Improvement CBO   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; IMIDAZOLE DERIVATIVE; LINCOSAMIDE DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DRUG USE; FEMALE; GENERAL HOSPITAL; HOSPITAL PATIENT; HUMAN; INAPPROPRIATE PRESCRIBING; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; TEACHING HOSPITAL; UNIVERSITY HOSPITAL;

EID: 78649481146     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.15.46.19715-en     Document Type: Article

References (17)

1. Cooke DM, Salter AJ, Phillips I. The impact of antibiotic policy on prescribing in a London teaching hospital. A oneday prevalence survey as an indicator of antibiotic use. J Antimicrob Chemother. 1983;11(5):447-53.
2. Ansari F, Erntell M, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) pointprevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49(10):1496-504.
3. Willemsen I, Groenhuijzen A, Bogaers D, Stuurman A, van Keulen P, Kluytmans J. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother. 2007;51(3):864-7.
4. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13(10):606-8.
5. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, editor. Hospital epidemiology and infection control. Philadelphia: Lippincott Williams & Wilkins: 2004. p. 1659-1702.
6. Gyssens IC, van den Broek PJ, Kullberg B, Hekster YA, van der Meer JWM. Optimizing antimicrobial therapy. A method for antimicrobial drug use evaluation. J Antimicrob Chemother. 1992;30:724-7.
7. Van Kasteren MEE, Wijnands WJ, Stobberingh EE, Janknegt R, Verbrugh HA, van der Meer JW. [Optimizing antibiotics use policy in the Netherlands. I. The Netherlands Antibiotics Policy Foundation (SWAB)]. Ned Tijdschr Geneeskd. 1998;142:949-51.
8. Dutch Working Party on Antibiotic Policy (SWAB). Nethmap 2008 - Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Amsterdam: SWAB; 2008. Available from: http://www.swab.nl/swab/swabcms.nsf/(WebFiles)/E32F6709B7DB7F2EC125744F002ACAA5/$FILE/NethMap_2008.pdf
9. Seaton RA, Nathwani D, Burtyon P, McLaughlin C, MacKenzie AR, Dundas S, Ziglam H, Gourlay Y, Beard K, Douglas E. Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT). Int J Antimicrob Agents. 2007;29(6):693-9.
10. Usluer G, Ozgunes I, Leblebicioglu H, Turkish Antibiotic Utilization Study Group. A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob. 2005;4:16.
11. Ang L, Laskar R, Gray JW. A point prevalence study of infection and antimicrobial use at a UK children's hospital. J Hosp Infect. 2008;68(4):372-4.
12. Howard D, Cordell R, McGowan JE Jr, Packard RM, Scott RD 2nd, Solomon SL; Workshop Group. Measuring the economic costs of antimicrobial resistance in hospital settings: summary of the Centers for Disease Control and Prevention-Emory Workshop. Clin Infect Dis. 2001;33(9):1573-8.
13. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42 Suppl 2:S82-9.
14. van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis. 2008;14(11):1722-30.
15. European Antimicrobial Resistance Surveillance System (EARSS). EARSS annual report 2008. Bilthoven: Netherlands Centre for Infectious Disease Control, National Institute for Public Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu, RIVM); 2009. Available from: http://www.ecdc.europa.eu/en/activities/surveillance/EARSNet/Documents/2008_EARSS_Annual_Report.pdf
16. van Hees BC, de Ruiter E, Wiltink EH, de Jongh BM, Tersmette M. Optimizing use of ciprofloxacin: a prospective intervention study. J Antimicrob Chemother. 2008;61(1):210-3.
17. Willemsen I, Cooper B, van Buitenen C, Winters M, Andriesse G, Kluytmans J. Improving quinolone use in hospitals by using a bundle of interventions in an interrupted time series analysis. Antimicrob Agents Chemother. 2010;54(9):3763-9.